Dr. Shafer's editorial on vaccination in the November issue of the ASA Monitor1 makes the following statements in favor of vaccination:

  • My parents, spouse, siblings, and children won't get COVID-19 from me.

  • My friends won't get COVID-19 from me.

  • My coworkers won't get COVID-19 from me.

  • My patients won't get COVID-19 from me.

To the best of my knowledge, no data suggest that vaccinated individuals who have breakthrough COVID-19 infections can't transmit COVID-19 to others, as the above text implies.

Sterling Wood, DO

Oceanport, New Jersey

1
Shafer
SL
.
How to Explain Vaccination to Your Unvaccinated Patients
.
ASA Monitor
2021
(November)

Dr. Wood is correct. Vaccinated patients with breakthrough infections can readily transmit COVID-19 to others. I did not anticipate that my text would be interpreted as he did, and I apologize for not being more precise. Point 2 of the editorial says, “I have reduced the risk of my passing COVID-19 to others.” In bullet points a, b, c, and d, I wanted to point out the many individuals who would not get COVID-19 if I didn't get COVID-19. I did not mean to imply that vaccinated individuals with breakthrough infections are unable to transmit COVID-19. While the secondary attack rate from vaccinated individuals with breakthrough infections (25%) is less than for unvaccinated individuals with COVID-19 (38%), it is still significant.1 I appreciate Dr. Wood bringing this to my attention and providing an opportunity to clarify this potential misunderstanding of my editorial.

1
Singanayagam
A
,
Hakki
S
,
Dunning
J.
et al
.
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
.
Lancet Infectious Disease
,
2021
(published ahead of print, https://doi.org/10.1016/S1473-3099(21)00648-4)

Steven L. Shafer, MD, FASA

Editor-in-Chief

ASA Monitor

∗ ∗ ∗

The views and opinions expressed in the “Letters to the Editor” are those of the authors and do not necessarily reflect the views of ASA or the ASA Monitor Editorial Board. Letters submitted for consideration should not exceed 300 words in length. The Editor-in-Chief has the authority to accept or reject any letter submitted for publication. Personal correspondence to the Editor by letter or e-mail must be clearly indicated as “Not for Publication” by the sender. Letters must be signed (although name may be withheld on request) and are subject to editing and abridgement. Send letters to ASAMonitor@asahq.org.